Serum Institute to send 1mn doses of Covishield to Nepal, Myanmar, Bangladesh

 Serum Institute to send 1mn doses of Covishield to Nepal, Myanmar, Bangladesh

A man walks past a signpost of India’s Serum Institute, the world’s largest maker of vaccines, which is developing a vaccine against the coronavirus disease at its laboratory in Pune, India, on 18 May 2020. | Reuters file photo

Serum Institute of India will export one million (10 lakh) Covishield doses each to Nepal, Myanmar and Bangladesh, to help them fight against the pandemic, sources said.

The move by the Pune-based Serum Institute — the Indian manufacturer of the AstraZeneca-Oxford vaccine — will fasten the vaccination in the respective countries.

So far, Serum Institute of India (SII) has supplied nearly 780 million doses of its Covid-19 vaccine Covishield and its target is to supply almost 215 million doses in the month of October, informed the sources to ANI on Friday.

Earlier, ANI reported on Friday, that the centre targets to procure 270-280 million vaccines this month and is expected to achieve one billion vaccinations before mid of October.

“The target of achieving this many doses will be from Serum Institute of India (SII) Covishield and Bharat Biotech’s Covid-19 vaccine Covaxin. India has procured more than 250 million in the month of September,” informed the sources.

Related post

Leave a Reply

Your email address will not be published. Required fields are marked *